Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors

被引：0
|
作者：
Keystone, E.
Pope, J. E.
Fleischmann, R.
Emery, P.
Chubick, A.
Dougados, M.
Baldassare, A. R.
Bathon, J. M.
Hessey, E.
Totoritis, M.
Cooper, S.
机构：
[1] Univ Toronto, Dept Rheumatol, Toronto, ON, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, London, ON N6A 4V2, Canada
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
[4] Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England
[5] Baylor Univ, Med Ctr, Ctr Arthritis, Dallas, TX USA
[6] Hop Cochin, Dept Rheumatol, F-75674 Paris, France
[7] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA
[8] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA
[9] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[10] Biogen Idec, San Diego, CA USA
来源：
JOURNAL OF RHEUMATOLOGY | 2007年 / 34卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1617 / 1618
页数：2
相关论文
共 50 条
  • [41] Prolonged efficacy of rituximab in rheumatoid arthritis patients with inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (Reflex study)
    Cohen, S.
    Emery, P.
    Greenwald, M.
    Dougados, M.
    Furie, R.
    Burmester, G.
    Williams, S.
    Cravets, M.
    Magrini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 183 - 183
  • [42] Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders
    Amano, Koichi
    Matsubara, Tsukasa
    Tanaka, Takaaki
    Inoue, Hiroshi
    Iwahashi, Mitsuhiro
    Kanamono, Toshihisa
    Nakano, Teruaki
    Uchimura, Shoichi
    Izumihara, Tomomaro
    Yamazaki, Akira
    Karyekar, Chetan S.
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 665 - 671
  • [43] Joint structural damage prevention with rituximab in patients with rheumatoid arthritis and an inadequate response to one or more TNF inhibitors: 1 year data from the reflex study
    Keystone, E.
    Kvien, T. K.
    Emery, P.
    Peterfy, C. D.
    Tak, P. P.
    Cohen, S.
    Genovese, M.
    Williams, S.
    Totoritis, M.
    Cravets, M.
    Shaw, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 14 - 14
  • [44] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Khraishi, M. M.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1602 - 1602
  • [45] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 178 - 179
  • [46] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    van Vollenhoven, R. F.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 11 - 11
  • [47] Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study
    Westhovens, R.
    Kremer, J. M.
    Emery, P.
    Russell, A. S.
    Alten, R.
    Barre, E.
    Dougados, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : 553 - 562
  • [48] Sustained efficacy and safety after a second treatment course of rituximab in patients with rheumatoid arthritis
    Szczepanski, L
    Szechinski, J
    Filipowicz-Sosnowska, A
    Nahir, M
    Pavelka, K
    Sheeran, T
    Emery, P
    Pope, J
    Saiedabadi, N
    Lehane, PB
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1392 - 1392
  • [49] Sustained efficacy and safety following a second treatment course of rituximab in patients with rheumatoid arthritis
    Emery, P
    Sheeran, T
    Szczepanski, L
    Szechinski, J
    Filipowicz-Sosnowska, A
    Nahir, M
    Pavelka, K
    Saiedabadi, N
    Lehane, PB
    RHEUMATOLOGY, 2005, 44 : I3 - I4
  • [50] LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF TOCILIZUMAB IN RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS
    Farah, Z.
    Reddy, V.
    Ali, S.
    Price-Kuehne, F.
    Moore, S.
    Mackworth-Young, C.
    Ehrenstein, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 734 - 735
12345